1,009 results on '"Gudasheva, T. A."'
Search Results
152. The Conformational Features of Some Biologically Active N-Acylprolyltyrosinamides Studied by 1H NMR Spectroscopy
153. Effects of Neurotensin Dipeptide Analog Dilept on Dopamine Metabolism and Synthesis in the Nucleus Accumbens of Wistar Rats
154. Neuroprotective properties of nootropic dipeptide GVS-111 inin vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress
155. Neuroprotective Properties of Nootropic Dipeptide GVS-111 in in Vitro Oxygen-Glucose Deprivation, Glutamate Toxicity and Oxidative Stress
156. In Vitro Study of Neuroprotective Properties of GK-2, a New Original Nerve Growth Factor Mimetic
157. Modulation of long-term memory by delayed administration of the amide of L-pyroglutamyl-D-alanine, a nootropic agent, in spaced and massed training in rats
158. Regional and Subcellular Localization of Cycloprolylglycine in Rat Brain
159. SYNTHESIS OF SUBSTITUTED DIPEPTIDE GB-115 AS A POTENTIAL SELECTIVE ANXIOLYTIC
160. P.814Survival of serum-deprived cells is mediated by antiapoptotic properties of BDNF small dipeptide mimetic
161. P.815Endogenous neuropeptide cycloprolylglycine involves in regulation of HIF-1-dependent pathway
162. P.613 New dipeptide mimetic of 2-nd loop of BDNF attenuates individual behavioral signs of opioid dependence in rats
163. GSB-106 Dipeptide Mimetic of Brain-Derived Neurotrophic Factor Prevents Anhedonia Development under Acute Social Defeat Stress Conditions in Mice
164. Screening study of nerve growth factor's and brain-derived neurotrophic factor's mimetics effects at the experimental depression model
165. The effects of cycloprolylglycine and its analogues on brain monoaminergic systems in BALB/c mice
166. Antidepressant-like activity of the dipeptide mimetic of brain-derived neurotrophic factor GSB-106 in Porsolt test after intraperitoneal sub-chronically and chronically treatment in mice
167. Study of ALM-802 orto-alkoxi analogues cardiotropic activity
168. Low molecular weight compound GSB-106 mimics the cellular effects of BDNF after serum deprivation
169. P.746 New types of activity of the BDNF dipeptide mimetic: An psychostimulant, anti-opioid and anti-craving effects in opiate dependent rodents
170. P.224 BAD activation is involved in survival-promoting effect of NGF and BDNF dipeptide mimetics
171. Effect of systemic administration of a new piracetam peptide analog on postresuscitation recovery of the central nervous system
172. Neuroprotective effect of dipeptide AVP(4-5)-NH2 is associated with nerve growth factor and heat shock protein HSP70
173. Noopept pharmacokinetics after intravenous administration of a lyophilized medicinal form in rats
174. Molecular design, synthesis and neuroleptic activity of dipeptide analogs of sulpride
175. The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-l-prolylglycine
176. Synthesis and nootropic activity of pyrrolidino[1,2-a]diazacycloalkanes
177. Effects of the nootropics piracetam and GVS-111 on voltage-dependent ion channels of neuronal membranes
178. Experimental study of the pharmacokinetics of a tryptophan-containing dipeptide GB-115
179. Synthesis of pyroglutamylasparagine amide dipeptide fragment of vasopressin, and the stereoselectivity of its Mnemic effect
180. Bioaccessibility of the new dipeptide nootropic drug noopept
181. Dipeptide Analog of Neurotensin Active Site Prevents the Development of Experimental Parkinson's Syndrome in Mice
182. Effect of Pyroglutamylasparagine Amide on Plastic Characteristics of Synaptic Transmission in the Hippocampus
183. 39. NEW NEUROPROTECTIVE ACYLPROLYL-CONTAINING DIPEPTIDE, GVS-111
184. Impairment of Learning and Memory after Photothrombosis of the Prefrontal Cortex in Rat Brain: Effects of Noopept
185. Endogenous Dipeptide Cycloprolylglycine Shows Selective Anxiolytic Activity in Animals with Manifest Fear Reaction
186. Pharmacokinetics of the New Potential Dipeptide Nootrope GVS-111 and Related Metabolites in Rat Brain
187. Anxiolytic Activity of Endogenous Nootropic Dipeptide Cycloprolylglycine in Elevated Plus-Maze Test
188. Nootropic action of proline-based topological analogs of piracetam
189. Antiamnesic effect of acyl-prolyl-containing dipeptide (GVS-111) in compression-induced damage to frontal cortex
190. SEARCH FOR NEW DRUGS: SYNTHESIS AND ANTIDOPAMINE EFFECT OF CONFORMATION-CONSTRAINED ANALOGS OF THE DIPEPTIDE NEUROLEPTIC DILEPT
191. Stereoselectivity of the Antidopamine Effect of N-Caproylprolyltyrosine Methylate – a Tripeptide Neurotensin Analog
192. Pharmacokinetics of new nootropic acylprolyldipeptide and its penetration across the blood-brain barrier after oral administration
193. L-pyroglutamyl-D-alanine amide normalizes functions of the developing rat brain disturbed by antenatal alcoholization
194. Piracetam peptide analog L-PGLU-D-Ala-NH2 maintains the plastic properties of synaptic transmission in long-lasting hippocampal slices
195. New endogenous dipeptide cycloprolyl-glycine is similar to piracetam by its mnemotropic selectivity
196. Psychotropic and Neuroreceptor Effects of Cyclopropylglycine Upon Intranasal Administration.
197. Low-Molecular-Weight Mimetic of BDNF Loop 2 Reduces Ethanol Consumption in Female Rats.
198. Dose-Dependent Effect of Nerve Growth Factor Mimetic GK-2 in a Wistar Rat Diabetes Model.
199. Synthesis and Cardiotropic Activity of bis-(2,3,4-Trimethoxybenzyl)Alkanediamines.
200. Memory restoring and neuroprotective effects of the proline-containing dipeptide, GVS-111, in a photochemical stroke model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.